B

BOLD

BOUNDLESS BIO INC

1.16

-0.03-2.11%
Closed16:00 08/01 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

-60.84M

-46.85M

-39.60M

-23.25M

Net Income

-65.36M

-49.43M

-45.90M

-25.21M

Depreciation/Depletion & Amortization

1.09M

957.00K

942.00K

682.00K

Deferred Taxes

--

--

--

--

Non-Cash Items

5.11M

2.42M

4.50M

2.12M

Changes in Working Capital

-1.68M

-799.00K

866.00K

-837.00K

Cash from Investing Activities

-26.10M

-38.26M

16.13M

-59.28M

Capital Expenditures

-2.54M

-633.00K

-1.07M

-2.03M

Other Investing Cash Flow Items, Total

-23.57M

-37.63M

17.20M

-57.25M

Cash from Financing Activities

89.82M

97.90M

126.00K

105.53M

Financing Cash Flow Items

--

-1.96M

0

--

Total Cash Dividends Paid

--

--

--

--

Issuance (Retirement) of Stock, Net

89.82M

99.85M

126.00K

105.53M

Issuance (Retirement) of Debt, Net

--

--

--

--

Foreign Exchange Effects

--

--

--

--

Net Change in Cash

2.88M

12.78M

-23.34M

22.99M

Cash Interest Paid

--

--

--

--

Cash Taxes Paid

--

--

--

--